Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
Journal of Chemical Information and Modeling|June 29, 2010
Selection of in silico drug screening results by using universal active probes (UAPs)Yoshifumi Fukunishi, Kazuki Ohno, Masaya Orita, et al.Molecular Genetics and Metabolism|May 21, 2008
Structural consequences of amino acid substitutions causing Tay-Sachs diseaseKazuki Ohno, Seiji Saito, Kanako Sugawara, et al.Molecular Genetics and Metabolism|December 6, 2011
Structural bases of Wolman disease and cholesteryl ester storage diseaseSeiji Saito, Kazuki Ohno, Toshihiro Suzuki, et al.Plos One|October 4, 2016
Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-SulfatasesSeiji Saito, Kazuki Ohno, Torayuki Okuyama, et al.Journal of Chemical Information and Modeling|April 10, 2009
In silico fragment screening by replica generation (FSRG) method for fragment-based drug designYoshifumi Fukunishi, Tadaaki Mashimo, Masaya Orita, et al.Expert Opinion on Drug Discovery|March 14, 2013
Advances in fragment-based drug discovery platformsMasaya Orita, Masaichi Warizaya, Yasushi Amano, et al.Marine Pollution Bulletin|August 18, 2020
Numerical modeling of the beach process of marine plastics: 2. A diagnostic approach with onshore-offshore advection-diffusion equations for buoyant plasticsHirofumi Hinata, Kazuki Ohno, Noa Sagawa, et al.Journal of Human Genetics|February 17, 2012
Database of the clinical phenotypes, genotypes and mutant arylsulfatase B structures in mucopolysaccharidosis type VISeiji Saito, Kazuki Ohno, Masakazu Sekijima, et al.Methods in Enzymology|March 5, 2011
Lead generation and examples opinion regarding how to follow up hitsMasaya Orita, Kazuki Ohno, Masaichi Warizaya, et al.Journal of Human Genetics|March 15, 2008
Structural study on mutant alpha-L-iduronidases: insight into mucopolysaccharidosis type IKanako Sugawara, Seiji Saito, Kazuki Ohno, et al.Pageof 6